Combating infectious diseases and the threat of antimicrobial resistance remains one of the greatest global challenges.
Professor Sharon Peacock explains the story behind the UK's world-leading SARS-CoV-2 genomics capability.
In the largest ever study of its kind into an equine pathogen, scientists in 18 countries used the latest DNA sequencing techniques to track the...
Diphtheria – a relatively easily-preventable infection – is evolving to become resistant to a number of classes of antibiotics and in future could...
Genomic surveillance – using information about genetic differences between virus samples – can help identify how SARS-CoV-2 spreads in care home...
New data from Addenbrooke's Hospital in Cambridge suggests that a single dose of the Pfizer BioNTech vaccine can reduce by 75% the number of...
A potential new treatment to protect immunosuppressed patients from human cytomegalovirus ( HCMV ) has been discovered by scientists at the...
The UK is a world leader in sequencing SARS-CoV-2, the virus that causes COVID-19. Of all the coronavirus genomes that have been sequenced in the...
SARS-CoV-2 mutations similar to those in the B1.1.7 UK variant could arise in cases of chronic infection, where treatment over an extended period can...
Global greenhouse gas emissions over the last century have made southern China a hotspot for bat-borne coronaviruses, by driving growth of forest...
Treating those most severely affected by COVID-19 has necessarily taken priority during the pandemic. But could long COVID be the next wave of the...
The vital role of ventilation in the spread of COVID-19 has been quantified by researchers, who have found that in poorly-ventilated spaces, the...
A new study, involving the University of Cambridge and led by the Pirbright Institute, has identified key genetic changes in SARS-CoV-2 - the virus...
